Ryan Braun’s name discovered in the Biogenesis records

68 Comments

From Jeff Passan and Tim Brown of Yahoo! Sports:

Milwaukee Brewers star Ryan Braun’s name is in records of the Miami-area clinic alleged to have distributed performance-enhancing drugs to a rash of baseball players, and Major League Baseball will investigate the link to the former MVP who tested positive for illegal synthetic testosterone during the 2011 postseason.

Braun was cleared of that 2011 positive test due to what was perceived to be an error in the handling of his urine sample. His name is not listed next to any specific PED transactions in the Biogenesis records, but Major League Baseball will investigate the matter in the hope of learning about the outfielder’s exact level of involvement.

Yankees catcher Francisco Cervelli and Orioles third baseman Danny Valencia were also discovered in the records at the Biogenesis clinic but, like Braun, were not listed in connection with a specific PED.

**********************

UPDATE, 11:21 PM: Braun says in a written statement that he used Bosch for consulting in his successful PED appeal and that he has “nothing to hide” —

“During the course of preparing for my successful appeal last year, my attorneys, who were previously familiar with Tony Bosch, used him as a consultant. More specifically, he answered questions about T/E ratio and possibilities of tampering with samples. There was a dispute over compensation for Bosch’s work, which is why my lawyer and I are listed under ‘moneys owed’ and not on any other list. I have nothing to hide and have never had any other relationship with Bosch. I will fully cooperate with any inquiry into this matter.”

Royals sign Drew Storen to minor league deal

Drew Storen
Getty Images
Leave a comment

The Royals are in agreement with right-handed reliever Drew Storen on a minor league deal, the team announced Friday. Per Jon Heyman of MLB Network, the deal is worth $1.25 million if the veteran righty breaks camp with the club this spring. Additional, albeit unspecified incentives will be included in the contract as well.

Storen, 31, is coming off of a protracted absence from any MLB duties. After inking a one-year deal with the Reds in 2017, he sustained a right elbow sprain toward the end of the year and underwent Tommy John surgery that October. He was effectively decommissioned for the club’s entire 2018 run and generated little interest around the league this winter, perhaps due in part to the uninspired 4.45 ERA, 3.8 BB/9, 7.9 SO/9, and career-low -0.2 fWAR he posted across 54 2/3 innings during his last healthy season.

While it’s not immediately clear what kind of performance the Royals can expect from Storen in spring training, they’re not exactly in a position to be choosy. Their bullpen ranked dead last among all MLB teams with a collective 5.04 ERA, 4.85 FIP, and -2.2 fWAR last year, and still appears to be in a state of flux as they approach Opening Day. Skipper Ned Yost told reporters Wednesday that he intends to eschew the traditional closer appointment in 2019 and will instead utilize a combination of right-handers Wily Peralta and Brad Boxberger, lefty Tim Hill, and various others as he tackles high-leverage situations in the future.